Accreditation Scheme for Conformity Assessment Program
Extension without change of a currently approved collection
No
Regular
Approved without change
08/01/2023
06/30/2023
The word "Pilot" has been removed from the ICR title in line with information provided in the supporting statement.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
08/31/2026
36 Months From Approved
07/31/2023
2,039
0
1,945
10,362
0
13,491
0
0
0
This information collection helps support implementation of sections 514 and 514(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360d and 360d(d)) which provide for the establishment of performance standards and authorizes the Accreditation Scheme for Conformity Assessment Program (ASCA Program). The ASCA program allows testing laboratories to be accredited by ASCA-recognized accreditation bodies to assess the conformance of a device to certain FDA-recognized standards.
Our estimated burden for the information collection reflects an overall decrease of 3,129 hours and an increase of 94 responses/records. We attribute this adjustment to an increase in renewal requests since the program was initiated.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.